Skip to content

13F-HR/A filed by STEMPOINT CAPITAL LP

STEMPOINT CAPITAL LP filed this 13F-HR/A for the quarter ended 2024-03-31, filed 2024-08-09, with 62 holding rows worth $378,329,825.

Accession
0001420506-24-001315
Filed
2024-08-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, amendment of type restatement, 63 entries on the cover page, a total value of $378,329,825 stated on the cover page (in dollars after the unit check, H1), rows summing to $378,329,825 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ROIVANT SCIENCES LTDG76279101SHS3,553,844$37,457,516dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock619,789$29,012,323dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM1,100,988$26,203,514dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM2,205,899$21,860,459dollars as filed
IMMUNOVANT INC45258J102COM627,228$20,265,737dollars as filed
AUTOLUS THERAPEUTICS PLC SPON05280R100COM2,965,721$18,921,300dollars as filed
AMICUS THERAPEUTICS INC03152W109COM1,547,141$18,225,321dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,003,916$17,126,807dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM1,161,060$13,770,172dollars as filed
Applied Therapeutics Inc03828A101Common Stock2,017,016$13,715,709dollars as filed
Eli Lilly and Company532457108COM15,067$11,721,523dollars as filed
MERUS N VN5749R100COM233,871$10,531,211dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock140,267$9,755,570dollars as filed
VISTAGEN THERAPEUTICS INC92840H400COM1,848,582$9,292,077dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK222,253$8,078,897dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock1,794,195$7,643,271dollars as filed
INSMED INC COM PAR $.01457669307Stock272,448$7,391,514dollars as filed
Tourmaline Bio Inc89157D105Common Stock274,219$6,279,615dollars as filed
ANAPTYSBIO INC032724106COM269,548$6,070,221dollars as filed
LARIMAR THERAPEUTICS INC517125100COM740,877$5,623,256dollars as filed
IMMATICS N.VN44445109SHS491,926$5,170,142dollars as filed
SOLENO THERAPEUTICS INC834203309COM115,833$4,957,652dollars as filed
ACELYRIN INC00445A100COM714,773$4,824,718dollars as filed
JANUX THERAPEUTICS INC47103J105COM121,642$4,579,821dollars as filed
BIOHAVEN LTDG1110E107COM83,461$4,564,482dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock90,647$4,553,199dollars as filed
ANNEXON INC03589W102COM605,117$4,338,689dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK407,108$3,843,100dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock87,393$3,834,805dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW129,211$3,793,635dollars as filed
AVADEL PHARMACEUTICALS PLCG29687103COM SHS223,660$3,777,617dollars as filed
DISC MEDICINE INC COM254604101Stock60,129$3,743,632dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK1,087,785$3,121,943dollars as filed
ASTRIA THERAPEUTICS INC COM04635X102Stock230,273$2,676,878dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW62,253$2,361,256dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS200,000$2,080,000dollars as filed
EFFECTOR THERAPEUTIC EQUCLASS EQUITY28202V207COMMON STOCK132,793$1,910,891dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK80,334$1,899,899dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK40,723$1,787,740dollars as filed
ACHILLES THERAPEUTICS PL-ADR00449L102COM1,385,750$1,732,188dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW26,893$1,641,011dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM43,456$1,303,680dollars as filed
CARGO THERAPEUTICS INC COM14179K101Stock51,126$1,141,132dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK500,000$1,075,000dollars as filedput
KYVERNA THERAPEUTICS INC501976104COMMON STOCK41,000$1,018,440dollars as filed
SPDR SER TR78464A870S&P BIOTECH1,200,000$876,000dollars as filedput
PROTARA THERAPEUTICS INC74365U107COM STK168,442$675,452dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM825,000$515,625dollars as filedput
IMMUNOVANT INC45258J102COM250,000$318,750dollars as filedcall
MERUS N VN5749R100COM85,000$212,500dollars as filedput
AVIDITY BIOSCIENCES INC COM05370A108Stock75,000$183,750dollars as filedcall
CRINETICS PHARMACEUTICALS INC COM22663K107Stock175,000$157,500dollars as filedput
ARCELLX INC COMMON STOCK03940C100Stock50,000$135,000dollars as filedput
BIOHAVEN LTDG1110E107COM30,000$121,500dollars as filedput
AMICUS THERAPEUTICS INC03152W109COM400,000$120,000dollars as filedcall
VERA THERAPEUTICS INC92337R101COMMON STOCK40,000$75,000dollars as filedput
KRYSTAL BIOTECH INC COM501147102Stock20,000$71,000dollars as filedput
AUTOLUS THERAPEUTICS PLC SPON05280R100COM250,000$68,750dollars as filedcall
ROIVANT SCIENCES LTDG76279101SHS750,000$56,250dollars as filedput
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK50,000$41,250dollars as filedput
PROTARA THERAPEUTICS INC74365U107COM STK87,900$13,185dollars as filedcall
UNITED THERAPEUTICS CORP DEL COM91307C102Stock10,000$10,750dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-24-000808 superseded2024-05-14acceptance time not in the bulk data set
13F-HR/A 0001420506-24-001315this filing2024-08-09acceptance time not in the bulk data set